Search by Drug Name or NDC

NDC 10135-0739-01 Tranylcypromine 10 mg/1 Details

Tranylcypromine 10 mg/1

Tranylcypromine is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Marlex Pharmaceuticals, Inc.. The primary component is TRANYLCYPROMINE SULFATE.

MedlinePlus Drug Summary

Tranylcypromine is used to treat depression in people who have not been helped by other medications. Tranylcypromine is in a class of medications called monoamine oxidase inhibitors (MAOIs). It works by increasing the amounts of certain natural substances that are needed to maintain mental balance.

Related Packages: 10135-0739-01
Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Tranylcypromine

Product Information

NDC	10135-0739
Product ID	10135-739_f6035bc0-37e7-d517-e053-2a95a90aa03d
Associated GPIs	58100030100305
GCN Sequence Number	046264
GCN Sequence Number Description	tranylcypromine sulfate TABLET 10 MG ORAL
HIC3	H7J
HIC3 Description	MAOIS -NON-SELECTIVE,IRREVERSIBLE ANTIDEPRESSANTS
GCN	16418
HICL Sequence Number	001640
HICL Sequence Number Description	TRANYLCYPROMINE SULFATE
Brand/Generic	Generic
Proprietary Name	Tranylcypromine
Proprietary Name Suffix	n/a
Non-Proprietary Name	Tranylcypromine
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	TABLET
Route	ORAL
Active Ingredient Strength	10
Active Ingredient Units	mg/1
Substance Name	TRANYLCYPROMINE SULFATE
Labeler Name	Marlex Pharmaceuticals, Inc.
Pharmaceutical Class	Monoamine Oxidase Inhibitor [EPC], Monoamine Oxidase Inhibitors [MoA]
DEA Schedule	n/a
Marketing Category	ANDA
Application Number	ANDA206856
Listing Certified Through	2024-12-31

Package

NDC 10135-0739-01 (10135073901)

Pricing Information	N/A
NDC Package Code	10135-739-01
Billing NDC	10135073901
Package	100 TABLET in 1 BOTTLE (10135-739-01)
Marketing Start Date	2022-05-01
NDC Exclude Flag	N